Cargando…
Receptor-driven invasion profiles in diffuse intrinsic pontine glioma
BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is a devastating pediatric cancer with unmet clinical need. DIPG is invasive in nature, where tumor cells interweave into the fiber nerve tracts of the pons making the tumor unresectable. Accordingly, novel approaches in combating the disease are o...
Autores principales: | Karki, Anju, Berlow, Noah E, Kim, Jin-Ah, Hulleman, Esther, Liu, Qianqian, Michalek, Joel E, Keller, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117434/ https://www.ncbi.nlm.nih.gov/pubmed/34013206 http://dx.doi.org/10.1093/noajnl/vdab039 |
Ejemplares similares
-
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma
por: Wang, Stacie S, et al.
Publicado: (2023) -
Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma
por: Lian, Xiaolei, et al.
Publicado: (2021) -
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
por: Duchatel, Ryan J, et al.
Publicado: (2021) -
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
por: Messinger, Dana, et al.
Publicado: (2022) -
Leptomeningeal disease and tumor dissemination in a murine diffuse intrinsic pontine glioma model: implications for the study of the tumor-cerebrospinal fluid-ependymal microenvironment
por: Pan, Shelei, et al.
Publicado: (2022)